A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 18, 2022

Primary Completion Date

October 18, 2025

Study Completion Date

October 18, 2026

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

digital subtraction angiography.

Each patient received an artery catheter procedure guided by digital subtraction angiography.

DRUG

FOLFOX (oxaliplatin , leucovorin , fluorouracil , and fluorouracil )

Hepatic artery infusion chemotherapy. The FOLFOX (oxaliplatin 130 mg/m2, leucovorin 200 mg/m2, fluorouracil 400 mg/m2, and fluorouracil 2,400 mg/m2) regimen was sequentially infused through the catheter every cycle (3 weeks).

Trial Locations (1)

500060

RECRUITING

Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER